Item Type | Name |
Concept
|
Amino Acids
|
Concept
|
Bile Acids and Salts
|
Concept
|
Carboxylic Acids
|
Concept
|
Docosahexaenoic Acids
|
Concept
|
Fatty Acids, Monounsaturated
|
Concept
|
Fatty Acids, Nonesterified
|
Concept
|
Fatty Acids
|
Concept
|
Fatty Acids, Unsaturated
|
Concept
|
Dicarboxylic Acids
|
Concept
|
Heptanoic Acids
|
Concept
|
Indoleacetic Acids
|
Concept
|
Sulfonic Acids
|
Concept
|
Fatty Acids, Omega-3
|
Concept
|
Fatty Acids, Omega-6
|
Concept
|
Fibric Acids
|
Academic Article
|
Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia.
|
Academic Article
|
The lipid-lowering effects of atorvastatin, a new HMG-CoA reductase inhibitor: results of a randomized, double-masked study.
|
Academic Article
|
Effect of marine lipids on cholesteryl ester transfer and lipoprotein composition in patients with hypercholesterolemia.
|
Academic Article
|
Effectiveness of atorvastatin for reducing low-density lipoprotein cholesterol to National Cholesterol Education Program treatment goals.
|
Academic Article
|
Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
|
Academic Article
|
Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.
|
Academic Article
|
Statin trials in progress: unanswered questions.
|
Academic Article
|
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia.
|
Academic Article
|
A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
|
Academic Article
|
The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
|
Academic Article
|
Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE)-rationale and design of atorvastatin versus usual care in hypercholesterolemic patients with coronary artery disease.
|
Academic Article
|
Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia.
|
Academic Article
|
Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
|
Academic Article
|
Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
|
Academic Article
|
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
|
Academic Article
|
Lipid responses in mildly hypertriglyceridemic men and women to consumption of docosahexaenoic acid-enriched eggs.
|
Academic Article
|
A multicenter, randomized, double-blind clinical trial comparing the low-density lipoprotein cholesterol-lowering ability of lovastatin 10, 20, and 40 mg/d with fluvastatin 20 and 40 mg/d.
|
Academic Article
|
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.
|
Academic Article
|
Lipid responses to a dietary docosahexaenoic acid supplement in men and women with below average levels of high density lipoprotein cholesterol.
|
Academic Article
|
Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin.
|
Academic Article
|
Reducing residual risk for patients on statin therapy: the potential role of combination therapy.
|
Academic Article
|
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin.
|
Academic Article
|
Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: an 8-week, randomized, double-blind, placebo-controlled study.
|
Academic Article
|
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
|
Academic Article
|
Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
|
Academic Article
|
Effects of high-fiber oat and wheat cereals on postprandial glucose and lipid responses in healthy men.
|
Academic Article
|
Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
|
Academic Article
|
Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.
|
Academic Article
|
ACAT inhibition and progression of carotid atherosclerosis in patients with familial hypercholesterolemia: the CAPTIVATE randomized trial.
|
Academic Article
|
Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction.
|
Academic Article
|
Baseline lipoprotein lipids and low-density lipoprotein cholesterol response to prescription omega-3 acid ethyl ester added to Simvastatin therapy.
|
Academic Article
|
Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
|
Academic Article
|
Effect of ACAT inhibition on the progression of coronary atherosclerosis.
|
Academic Article
|
Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
|
Academic Article
|
Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
|
Academic Article
|
High-dose statins in acute coronary syndromes.
|
Academic Article
|
Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting.
|
Academic Article
|
Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme.
|
Academic Article
|
A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia.
|
Academic Article
|
Novel developments in omega-3 fatty acid-based strategies.
|
Academic Article
|
Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor.
|
Academic Article
|
Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
|
Academic Article
|
Omega-3 fatty acid concentrates in the treatment of moderate hypertriglyceridemia.
|
Academic Article
|
Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study.
|
Academic Article
|
Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial.
|
Academic Article
|
Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS).
|
Academic Article
|
Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups.
|
Academic Article
|
Torcetrapib/atorvastatin combination therapy.
|
Academic Article
|
Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids.
|
Academic Article
|
Therapies targeting exogenous cholesterol uptake: new insights and controversies.
|
Academic Article
|
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial.
|
Academic Article
|
Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety.
|
Academic Article
|
Maintenance of lower proportions of (n - 6) eicosanoid precursors in phospholipids of human plasma in response to added dietary (n - 3) fatty acids.
|
Academic Article
|
Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial.
|
Academic Article
|
Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans.
|
Academic Article
|
Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease?
|
Academic Article
|
A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
|
Academic Article
|
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia.
|
Academic Article
|
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting.
|
Academic Article
|
Marine oil capsule therapy for the treatment of hyperlipidemia.
|
Academic Article
|
Bile acid excretion and patterns of fatty acid absorption in formula-fed premature infants.
|
Academic Article
|
Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
|
Academic Article
|
Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial.
|
Academic Article
|
Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease.
|
Academic Article
|
Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
|
Academic Article
|
Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid.
|
Academic Article
|
ETC-1002: a future option for lipid disorders?
|
Academic Article
|
A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
|
Academic Article
|
A STUDY OF BLOOD GLUCOSE AND KETONE BODIES AND PLASMA FREE FATTY ACIDS, CHOLESTEROL, PHOSPHOLIPIDS AND TOTAL LIPIDS IN JUVENILE DIABETES.
|
Academic Article
|
Purification and characterization of two soluble cytochromes from the alkalophile Bacillus firmus RAB.
|
Academic Article
|
The response of blood glucose, ketones, and plasma nonesterified fatty acids to fasting and epinephrine injection in infants and children.
|
Academic Article
|
Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.
|
Academic Article
|
RE: Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.
|
Academic Article
|
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).
|
Academic Article
|
Lipid-induced insulin resistance is associated with increased monocyte expression of scavenger receptor CD36 and internalization of oxidized LDL.
|
Academic Article
|
Olestra's effect on vitamins D and E in humans can be offset by increasing dietary levels of these vitamins.
|
Academic Article
|
Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial.
|
Academic Article
|
The future of n-3 polyunsaturated fatty acid therapy.
|
Academic Article
|
Fine mapping of mitochondrial RNAs derived from the mtDNA region containing a point mutation associated with MELAS.
|
Academic Article
|
Omega-3 carboxylic acids monotherapy and combination with statins in the management of dyslipidemia.
|
Academic Article
|
Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
|
Academic Article
|
No Effect of Omega-3 Carboxylic Acids on Pharmacokinetics/Pharmacodynamics of Warfarin or on Platelet Function When Co-administered with Acetylsalicylic Acid: Results of Two Phase I Studies in Healthy Volunteers.
|
Academic Article
|
The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia.
|
Academic Article
|
Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
|
Academic Article
|
Evolution of Omega-3 Fatty Acid Therapy and Current and Future Role in the Management of Dyslipidemia.
|
Academic Article
|
Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial.
|
Academic Article
|
Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial.
|
Academic Article
|
?-6 Polyunsaturated Fatty Acids and Cardiometabolic Health: Current Evidence, Controversies, and Research Gaps.
|
Academic Article
|
Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
|
Academic Article
|
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial.
|
Academic Article
|
The clinical black, white, and gray lessons.
|